Benitec Biopharma Ltd., of Balmain, Australia, reduced the number of American depository shares (ADSs) but added warrants in its planned U.S. IPO. The company, whose shares trade on the Australian Securities Exchange as BLT, will seek to raise $25 million by offering 1.9 million ADSs and warrants to purchase 500,000 ADSs at $13.55 apiece. Each ADS includes 0.28 of a warrant to purchase one ADS at the offering price.